Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:CLVR

Clever Leaves Q2 2023 Earnings Results & Report

Clever Leaves logo
$0.01 0.00 (0.00%)
As of 10/16/2026

Clever Leaves reported Q2 2023 earnings on August 14, 2023. The company reported EPS of -$2.10, while revenue was $4.98 million.

Earnings Announcement Details

Quarter
Q2 2023
Report Date

Clever Leaves EPS Results

Actual EPS
-$2.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Clever Leaves Revenue Results

Actual Revenue
$4.98 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Clever Leaves' next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules.

Conference Call Resources

Clever Leaves Q2 2023 Earnings FAQ

Clever Leaves (NASDAQ:CLVR) reported earnings of -$2.10 per share for Q2 2023. The report was announced on Monday, August 14, 2023.

Clever Leaves reported revenue of $4.98 million for Q2 2023.

Clever Leaves' next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Clever Leaves on the company's earnings history page.

Clever Leaves Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Clever Leaves Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Clever Leaves? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clever Leaves and other key companies, straight to your email.

About Clever Leaves

Clever Leaves (NASDAQ:CLVR) is a cannabis company focused on the cultivation, processing, manufacturing and distribution of pharmaceutical-grade cannabis products. The company has developed capabilities across the cannabis supply chain, including cultivation, extraction and the production of cannabis flower, oils, extracts and other cannabinoid-based ingredients.

Clever Leaves primarily operates as a business-to-business supplier, serving pharmaceutical companies, medical-cannabis operators and other commercial partners. Its products and services are intended for regulated medical and wellness markets, subject to applicable local laws and regulatory requirements.

Founded in 2017, the company built cultivation and processing operations in Colombia and expanded its international presence through facilities and partnerships in markets including Portugal, Germany and other regions where medical cannabis is permitted. Clever Leaves has historically emphasized international cannabis production and distribution, particularly in Europe and Latin America.

View Clever Leaves Profile